<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of our survey is to analyse the clinical approach used to prevent and treat cardiovascular implantable electronic device (CIED) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> in Europe </plain></SENT>
<SENT sid="1" pm="."><plain>The survey involves high-volume implanting centres </plain></SENT>
<SENT sid="2" pm="."><plain>According to the survey the incidence of CIED <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> shows a slight decrease in most centres and is substantially under 2% in the majority of centres interviewed </plain></SENT>
<SENT sid="3" pm="."><plain>However, there are still differences in terms of prophylactic antibiotic therapy: 8.9% of the centres administer <z:chebi fb="0" ids="7809">oxacillin</z:chebi> as preoperative treatment, 4.4% of them do not give any antibiotic therapy, <z:hpo ids='HP_0000001'>all</z:hpo> centres use some kind of skin antisepsis, but only 42.2% use <z:chebi fb="2" ids="3614">chlorhexidine</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In case of local <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, 43.5% of centres perform lead extraction as first approach </plain></SENT>
<SENT sid="5" pm="."><plain>In the case of <z:e sem="disease" ids="C0243026" disease_type="Disease or Syndrome" abbrv="">systemic infection</z:e> or evidence of lead or valvular <z:hpo ids='HP_0100584'>endocarditis</z:hpo>, 95% of centres treat these conditions by extracting the leads, which indicates that the adherence to the lead extraction guidelines is quite good </plain></SENT>
</text></document>